ELOX
Eloxx Pharmaceuticals, Inc.
There isn't enough reported data to score ELOX yet.
ELOX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
ELOX's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
ELOX PE Valuation
ELOX has no meaningful PE right now: it lost money over the past year.
ELOX Forward outlook
There aren't enough analyst estimates for ELOX to show an outlook.
ELOX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2022 | -$184.80 | +$264.00 |
| Q2 2022 | -$193.60 | +$277.20 |
| Q1 2022 | -$378.40 | -$57.20 |
| Q4 2021 | -$418.00 | -$39.60 |
| Q3 2021 | -$448.80 | -$8.80 |
| Q2 2021 | -$470.80 | +$39.60 |
| Q1 2021 | -$321.20 | +$277.20 |
| Q4 2020 | -$378.40 | +$211.20 |
ELOX is still losing money, but far less than before: $184.80 per share over the past year, against $646.80 at its worst in early 2019.
ELOX Quarterly Revenue
ELOX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.8M | -$3M |
| Q1 2026 | -$5.5M | -553% |
| Q3 2023 | -$3.5M | +$3.5M |
| Q2 2023 | -$2.1M | +$7.7M |
| Q1 2023 | -$6.8M | +$2.7M |
| Q4 2022 | -$5.7M | +$4.3M |
| Q2 2022 | -$9.8M | +$43K |
| Q1 2022 | -$9.5M | -$1.8M |
ELOX has burned cash in almost every quarter: −$11M over the past year, against −$18M the year before.
ELOX Net Leverage
ELOX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ELOX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.3 | Neutral |
| Stochastic | 11.7 | Oversold |
ELOX's weekly RSI is 49 (neutral) and its Stochastic is 12 (oversold).
ELOX PE vs Healthcare Sector
ELOX has no meaningful PE right now: it lost money over the past year.
ELOX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.6 | 5.3% below |
| 20 week MA | $14.8 | 13% below |
ELOX is in a downtrend: it's below all two of its weekly moving averages, and 13% below its 20-week average.
ELOX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $13.5 | $12.9 | -4.7% |
It's down 4.7% so far in 2026.